JP2022532134A5 - - Google Patents

Info

Publication number
JP2022532134A5
JP2022532134A5 JP2021566259A JP2021566259A JP2022532134A5 JP 2022532134 A5 JP2022532134 A5 JP 2022532134A5 JP 2021566259 A JP2021566259 A JP 2021566259A JP 2021566259 A JP2021566259 A JP 2021566259A JP 2022532134 A5 JP2022532134 A5 JP 2022532134A5
Authority
JP
Japan
Prior art keywords
sequence
referred
peptide ligand
cysteine residues
amino acids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021566259A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022532134A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/GB2020/051144 external-priority patent/WO2020225577A1/en
Publication of JP2022532134A publication Critical patent/JP2022532134A/ja
Publication of JP2022532134A5 publication Critical patent/JP2022532134A5/ja
Pending legal-status Critical Current

Links

JP2021566259A 2019-05-09 2020-05-11 Ox40に特異的な二環式ペプチドリガンド Pending JP2022532134A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962845473P 2019-05-09 2019-05-09
US62/845,473 2019-05-09
PCT/GB2020/051144 WO2020225577A1 (en) 2019-05-09 2020-05-11 Bicyclic peptide ligands specific for ox40

Publications (2)

Publication Number Publication Date
JP2022532134A JP2022532134A (ja) 2022-07-13
JP2022532134A5 true JP2022532134A5 (cg-RX-API-DMAC7.html) 2023-05-17

Family

ID=70847426

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021566259A Pending JP2022532134A (ja) 2019-05-09 2020-05-11 Ox40に特異的な二環式ペプチドリガンド

Country Status (12)

Country Link
US (1) US11613560B2 (cg-RX-API-DMAC7.html)
EP (1) EP3965827A1 (cg-RX-API-DMAC7.html)
JP (1) JP2022532134A (cg-RX-API-DMAC7.html)
KR (1) KR20220007098A (cg-RX-API-DMAC7.html)
CN (1) CN113811541A (cg-RX-API-DMAC7.html)
AU (1) AU2020269506A1 (cg-RX-API-DMAC7.html)
BR (1) BR112021022315A2 (cg-RX-API-DMAC7.html)
CA (1) CA3137095A1 (cg-RX-API-DMAC7.html)
IL (1) IL287881A (cg-RX-API-DMAC7.html)
MX (1) MX2021013669A (cg-RX-API-DMAC7.html)
SG (1) SG11202111606TA (cg-RX-API-DMAC7.html)
WO (1) WO2020225577A1 (cg-RX-API-DMAC7.html)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ731185A (en) 2014-10-29 2024-03-22 Bicyclerd Ltd Bicyclic peptide ligands specific for mt1-mmp
WO2019002842A1 (en) 2017-06-26 2019-01-03 Bicyclerd Limited BICYCLIC PEPTIDE LIGANDS WITH DETECTABLE FRACTIONS AND USES THEREOF
JP7670481B2 (ja) 2017-08-04 2025-04-30 バイスクルテクス・リミテッド Cd137に対して特異的な二環式ペプチドリガンド
TWI825046B (zh) 2017-12-19 2023-12-11 英商拜西可泰克斯有限公司 Epha2特用之雙環胜肽配位基
CA3091775A1 (en) 2018-02-23 2019-08-29 Bicycletx Limited Multimeric bicyclic peptide ligands
GB201810316D0 (en) 2018-06-22 2018-08-08 Bicyclerd Ltd Peptide ligands for binding to EphA2
US11180531B2 (en) 2018-06-22 2021-11-23 Bicycletx Limited Bicyclic peptide ligands specific for Nectin-4
GB201820325D0 (en) 2018-12-13 2019-01-30 Bicyclerd Ltd Bicyclic peptide ligands specific for psma
GB201820288D0 (en) 2018-12-13 2019-01-30 Bicycle Tx Ltd Bicycle peptide ligaands specific for MT1-MMP
GB201820295D0 (en) 2018-12-13 2019-01-30 Bicyclerd Ltd Bicyclic peptide ligands specific for MT1-MMP
WO2020128527A1 (en) 2018-12-21 2020-06-25 Bicyclerd Limited Bicyclic peptide ligands specific for pd-l1
EP3897849A1 (en) 2018-12-21 2021-10-27 BicycleTx Limited Bicyclic peptide ligands specific for pd-l1
GB201900529D0 (en) 2019-01-15 2019-03-06 Bicycletx Ltd Bicyclic peptide ligands specific for CD38
KR20220007098A (ko) 2019-05-09 2022-01-18 바이사이클티엑스 리미티드 Ox40에 특이적인 이환식 펩티드 리간드
TWI860386B (zh) 2019-07-30 2024-11-01 英商拜西可泰克斯有限公司 異質雙環肽複合物
SI4464721T1 (sl) * 2019-10-03 2025-08-29 Bicycletx Limited Heterotandemski biciklični peptidni kompleksi
CN116348476A (zh) 2020-08-03 2023-06-27 拜斯科技术开发有限公司 基于肽的接头
CA3206529A1 (en) * 2021-01-08 2022-07-14 Bicycletx Limited Heterotandem bicyclic peptide complexes
JP2024504068A (ja) * 2021-01-08 2024-01-30 バイスクルテクス・リミテッド 抗感染性二環式ペプチドリガンド
US12539335B2 (en) 2021-09-29 2026-02-03 Conjustar (Zhuhai) Biologics Co., Ltd. Tricyclic polypeptide conjugated drug and use thereof
CN114933638B (zh) * 2022-05-12 2024-07-26 厦门大学 特异性靶向cd28的多元环肽配体框架

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6927203B1 (en) 1999-08-17 2005-08-09 Purdue Research Foundation Treatment of metastatic disease
EP1452868A2 (en) 2003-02-27 2004-09-01 Pepscan Systems B.V. Method for selecting a candidate drug compound
JP6074574B2 (ja) 2008-02-05 2017-02-08 バイシクル セラピューティクス リミテッド 方法及び組成物
GB0913775D0 (en) 2009-08-06 2009-09-16 Medical Res Council Multispecific peptides
WO2012057624A1 (en) 2010-10-25 2012-05-03 Pepscan Systems B.V. Novel bicyclic peptide mimetics
US9828432B2 (en) * 2012-02-06 2017-11-28 Providence Health & Services—Oregon Cancer treatment and monitoring methods using OX40 agonists
ES2705068T3 (es) 2013-05-23 2019-03-21 Ohio State Innovation Foundation Síntesis química y cribado de bibliotecas de péptidos bicíclicos
PT3149025T (pt) 2014-05-21 2019-08-01 Entrada Therapeutics Inc Peptídeos penetrantes de células e métodos de fabrico e utilização dos mesmos
NZ731185A (en) 2014-10-29 2024-03-22 Bicyclerd Ltd Bicyclic peptide ligands specific for mt1-mmp
MX2017016844A (es) * 2015-07-16 2018-08-15 Biokine Therapeutics Ltd Composiciones y procedimientos para tratar cancer.
KR102775461B1 (ko) 2016-04-01 2025-02-28 어비디티 바이오사이언시스 인크. 핵산-폴리펩타이드 조성물 및 이의 용도
BR112018071612A2 (pt) 2016-04-22 2019-02-19 Alligator Bioscience Ab polipeptídeos biespecíficos inovadores contra cd137
GB201607827D0 (en) * 2016-05-04 2016-06-15 Bicycle Therapeutics Ltd Bicyclic peptide-toxin conjugates specific for MT1-MMP
EP3559018A1 (en) 2016-12-23 2019-10-30 Bicyclerd Limited Peptide derivatives having novel linkage structures
BR112019017628A2 (pt) 2017-02-24 2020-07-07 Macrogenics, Inc. molécula de ligação a cd137 x ta, composições farmacêuticas, uso da molécula de ligação a cd137 x ta, molécula de ligação a cd137, uso da molécula de ligação a cd137, molécula de ligação a her2/neu, uso da molécula de ligação a her2/neu, e uso de uma composição
JP7670481B2 (ja) 2017-08-04 2025-04-30 バイスクルテクス・リミテッド Cd137に対して特異的な二環式ペプチドリガンド
TWI825046B (zh) 2017-12-19 2023-12-11 英商拜西可泰克斯有限公司 Epha2特用之雙環胜肽配位基
GB201721265D0 (en) 2017-12-19 2018-01-31 Bicyclerd Ltd Bicyclic peptide ligands specific for EphA2
CA3091775A1 (en) 2018-02-23 2019-08-29 Bicycletx Limited Multimeric bicyclic peptide ligands
CA3095582A1 (en) 2018-04-04 2019-10-10 Bicycletx Limited Heterotandem bicyclic peptide complexes
US11180531B2 (en) 2018-06-22 2021-11-23 Bicycletx Limited Bicyclic peptide ligands specific for Nectin-4
GB201810316D0 (en) 2018-06-22 2018-08-08 Bicyclerd Ltd Peptide ligands for binding to EphA2
WO2020084305A1 (en) 2018-10-23 2020-04-30 Bicycletx Limited Bicyclic peptide ligands and uses thereof
EP3897849A1 (en) 2018-12-21 2021-10-27 BicycleTx Limited Bicyclic peptide ligands specific for pd-l1
US20220184222A1 (en) 2019-04-02 2022-06-16 Bicycletx Limited Bicycle toxin conjugates and uses thereof
KR20220007098A (ko) 2019-05-09 2022-01-18 바이사이클티엑스 리미티드 Ox40에 특이적인 이환식 펩티드 리간드
TWI860386B (zh) 2019-07-30 2024-11-01 英商拜西可泰克斯有限公司 異質雙環肽複合物
SI4464721T1 (sl) 2019-10-03 2025-08-29 Bicycletx Limited Heterotandemski biciklični peptidni kompleksi
CN114760988A (zh) 2019-11-27 2022-07-15 拜斯科技术开发有限公司 对EphA2具有特异性的双环肽配体和其用途
EP4165414A1 (en) 2020-06-12 2023-04-19 BicycleTX Limited Treatment of diseases characterized by overexpression of erythropoietin-producing hepatocellular receptor a2 (epha2)

Similar Documents

Publication Publication Date Title
JP2022514687A5 (cg-RX-API-DMAC7.html)
AU2020378282B2 (en) Dual IL-2R and IL-7R binding compounds
JP7427286B2 (ja) IL-2RβγC結合化合物
TWI812918B (zh) IL-7Rαγc結合化合物
CA3101427A1 (en) Bicyclic peptide ligands specific for nectin-4
JP2022514255A5 (cg-RX-API-DMAC7.html)
JP2022517040A5 (cg-RX-API-DMAC7.html)
JP2022518695A5 (cg-RX-API-DMAC7.html)
JP2022518210A5 (cg-RX-API-DMAC7.html)
JP2022532134A (ja) Ox40に特異的な二環式ペプチドリガンド
JP2022513223A5 (cg-RX-API-DMAC7.html)
CN108368511B (zh) 单链cd137受体激动剂蛋白
EP4268901A2 (en) Il-2r beta-gamma c binding compounds and uses thereof
JP2022515720A5 (cg-RX-API-DMAC7.html)
US20220119492A1 (en) Il-2r-beta-gamma binding compounds and uses thereof
JP2023524995A5 (cg-RX-API-DMAC7.html)
JP2020537690A (ja) プレクチン1結合抗体およびその使用
JP2023520714A5 (cg-RX-API-DMAC7.html)
JP2022515721A5 (cg-RX-API-DMAC7.html)
WO2024223892A1 (en) Bispecific fusion proteins with immunosuppressive activity
TW202528536A (zh) IL—2Rβγ促效劑肽在細胞製造中之用途
JP2023501720A5 (cg-RX-API-DMAC7.html)
IL256261A (en) Compounds and method for hide1